Clinical Trial Update: ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for ZD 1839 in stage IV or recurrent kidney cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• ZD 1839

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED